I am captivated by how biology shows us that matter can be made programmable. I took this lens seriously first as a way to work on substance addiction, a pathology that starts with a disequilibrated brain, and often cascades into toxin-induced degeneration through the rest of the body. I built systems—like compilers for biochemical machine code—to design molecules that extinguish substance cravings in animal models1, then make cells more stress-resilient to eventually create regenerative therapies2. I then realized clinical infrastructure would bottleneck the rate at which therapeutic ideas like these could be tested, so I worked on LMs to help underwrite new drug trials3. Now, I’m working on a more general blueprint for cures, and using biotech markets to scale their deployment and access feedback4.